Liraglutide vs Tirzepatide: Full Comparison of Weight-Loss Results, Side Effects & Cost
Both injections help adults lose weight—but one is daily and the other weekly, and average weight loss can differ by more than 2-fold. See which fits your lifestyle, risk factors and wallet.
Tirzepatide typically leads to almost three times more weight loss than liraglutide in head-to-head clinical trials, largely because it targets both GIP and GLP-1 receptors while liraglutide only targets GLP-1. Tirzepatide is injected once a week, while liraglutide requires a daily shot, and both drugs have similar gastrointestinal side-effects but different convenience and price points. Adults with a higher starting body-mass index (BMI) or who need the greatest weight-loss “power” usually lean toward tirzepatide, whereas liraglutide is a proven alternative when weekly twincretin supplies are tight or insurance will only cover a single-agonist GLP-1.
- Tirzepatide is given once every 7 days, while liraglutide requires 365 injections a year—convenience can boost adherence.
- Liraglutide is available as generic Victoza, so patients with strong insurance coverage sometimes pay under $25/month, whereas cash price for tirzepatide averages $1,072 before discounts.
- Tirzepatide can be purchased online for $149 through a 503a pharmacy online through Rx.com with a quick intake form (less than 2 min)
- Neither drug is safe in pregnancy or for people with a personal or family history of medullary thyroid cancer—talk to your endocrinologist before starting.
What Liraglutide and Tirzepatide Are
Liraglutide is a once-daily GLP-1 receptor agonist first approved as Victoza for type 2 diabetes and later as Saxenda for chronic weight management. Tirzepatide, branded as Mounjaro for diabetes and Zepbound for obesity, is a dual GIP/GLP-1 “twincretin” given once weekly. Both mimic gut hormones that increase satiety, slow stomach emptying and fine-tune insulin release. FDA approvals require adults to combine the injections with diet and exercise. [fda.gov]
GLP-1 drugs comparison: If you’re still deciding among Ozempic, Wegovy and others, our GLP-1 comparison guide explains every option side-by-side.
How the Two Injections Work Differently
Tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, while liraglutide activates only GLP-1 receptors. Dual agonism appears to amplify appetite suppression and energy expenditure, producing larger calorie deficits.
Brain satiety centers: Functional MRI studies show tirzepatide dampens activity in hunger-related hypothalamic regions more than liraglutide, translating into smaller portion sizes at meals.
Gastric emptying: Both slow stomach transit, but tirzepatide’s effect plateaus over time, reducing chronic nausea risk.
New to these hormones? How GLP-1 makes you feel walks through the brain–gut science in plain English.
How Much Weight You Can Expect to Lose
Clinical trials report an average 17-21 % total body-weight reduction with tirzepatide 10–15 mg at 72 weeks versus roughly 8 % with liraglutide 3 mg at 56 weeks. Real-world loss is often a few points lower because some people stop early or miss doses.
| Drug & Dose | Trial | Duration (weeks) | Mean % Weight Loss |
|---|---|---|---|
| Tirzepatide 15 mg weekly | SURMOUNT-1 | 72 | 21 % |
| Tirzepatide 10 mg weekly | SURMOUNT-1 | 72 | 17 % |
| Liraglutide 3 mg daily | SCALE Obesity & Prediabetes | 56 | 7.9 % |
| Placebo lifestyle only | Both trials | 56-72 | 2.4 % |
Who loses the most: People who reach at least 4 % loss by week 12 on either drug almost always hit ≥10 % by one year.[pubmed.ncbi.nlm.nih.gov]
Ready to start a weight-loss prescription?
Licensed U.S. providers on Rx.com can prescribe and ship GLP-1 medications to your door—see if you qualify in minutes.
Dosing Schedules and Ease of Use
Tirzepatide wins on convenience with one weekly injection, while liraglutide demands daily commitment. Both use pre-filled pens with tiny 32-gauge needles.
| Drug | Titration Steps | Maintenance Range | Total Injections/Year |
|---|---|---|---|
| Tirzepatide | 2.5→5→7.5→10→12.5→15 mg | 5–15 mg weekly | 52 |
| Liraglutide | 0.6→1.2→1.8→2.4→3.0 mg | 3.0 mg daily | 365 |
Struggling with titration? Our GLP-1 titration scheduling guide shares calendar templates to keep you on track.
Side-Effects and Safety Compared
Both drugs mainly cause temporary GI symptoms, but overall discontinuation rates are similar—around 6 %.
Nausea & vomiting: Peaks during dose escalation and fades after week 20 for most. Eat smaller meals and avoid high-fat foods.
Gallbladder disease: Occurs in roughly 0.8 % of liraglutide and 0.6 % of tirzepatide users—rapid weight loss itself is a contributor.
Pancreatitis risk: Extremely rare (<0.3 %). Seek care for sudden severe upper-abdominal pain.
Wondering why side effects happen? Managing tirzepatide nausea has tips that apply to both medications.
Cost, Insurance & Discounts
Cash list price runs about $1,352 for a 30-day supply of liraglutide pens and $1,072 for a month of tirzepatide, but insurance coverage and coupons change everything.
| Scenario | Liraglutide (30 days) | Tirzepatide (28 days) |
|---|---|---|
| Manufacturer list price | $1,352 | $1,072 |
| Average Rx.com coupon price | $423 | $511 |
| Typical commercial copay | $25–$75 | $35–$90 |
| Medicare Part D (Tier 3) | Subject to deductible | Often not covered for obesity alone |
Tip: Use Rx.com to compare real-time prices—most patients pay well under the sticker price with a free discount card.
Not sure which shot fits your situation?
Check the column that fits your situation:
✅ Tirzepatide makes sense
- BMI ≥35 kg/m² and goal ≥15 % weight loss
- You prefer once-weekly injections
- Insurance or an HSA will cover most of the cost
- You have type 2 diabetes needing A1C reduction
🏥 Liraglutide may be smarter
- Daily injections don’t bother you
- Your plan covers Victoza/Saxenda but excludes Zepbound
- You only need 5-10 % weight loss to improve health markers
- You experienced intolerable GI effects on higher GLP-1 doses
How to Decide Which Is Right for You
Match the drug to your weight-loss goal, budget and tolerance for injections.
Goal size: Clinical guidelines recommend aiming for ≥15 % loss when treating obesity-related comorbidities—a target tirzepatide hits in 7 out of 10 users. Liraglutide reaches that mark in about 2 out of 10.
Adherence: If you’ve struggled to remember daily pills, a weekly shot can remove 313 extra chances to forget.
Coverage quirks: Some insurers still classify obesity treatment as “lifestyle.” If Saxenda is Tier 2 while Zepbound is not listed, daily may trump weekly.
Need more help choosing? Deciding on GLP-1 medication walks through insurance scripts and appeal letters.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe, persistent abdominal pain — could signal pancreatitis
- Yellowing of skin or eyes — possible gallstones or hepatitis
- Difficulty breathing or swelling of face/throat — signs of allergic reaction
- Vision changes — sudden blurriness or floaters warrant an eye exam
- Palpitations or chest pain — rare cases of tachycardia reported
- Black or bloody stools — GI bleeding requires urgent care
- Thoughts of self-harm — mood changes can occur on any chronic med
- Unable to keep liquids down for 24 hrs — risk of dehydration
Scientific References
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med, 2022.
- Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med, 2015.
- Frias JP et al. Weight Reduction Over Time in Tirzepatide-Treated Participants by Early Response: SURMOUNT-1 Post Hoc Analysis. Diabetes Obes Metab, 2025.
- Ludvik B et al. Gastrointestinal Tolerability and Weight Reduction with Tirzepatide in SURMOUNT-1 to -4. Obesity, 2024.
- U.S. FDA. Approval of Zepbound (tirzepatide) for Chronic Weight Management, 2023.
- U.S. FDA. Approval of Generic Liraglutide Injection, 2024.
Frequently Asked Questions
Is tirzepatide stronger than liraglutide?
Yes. In randomized trials tirzepatide 15 mg produced about 21 % weight loss versus 8 % with liraglutide 3 mg, so it’s considered the more potent option.
Can I switch from liraglutide to tirzepatide?
You can, but your prescriber will restart the dose-escalation schedule beginning at 2.5 mg weekly. See our guide on switching between GLP-1s for step-by-step timing.
Which drug lowers A1C more?
Among people with type 2 diabetes, tirzepatide lowers A1C by up to 2.1 percentage points, about double the reduction seen with liraglutide at maximum dose.
Do both shots cause hair loss?
Hair shedding happens primarily from rapid weight loss, not the drug itself. Rates are similar between the two injections at under 3 %.
Is tirzepatide FDA-approved for weight loss?
Yes—Zepbound (tirzepatide) received FDA approval for chronic weight management in November 2023. Mounjaro is the same molecule approved for diabetes.
Will Medicare pay for these medications?
Medicare Part D can cover GLP-1 drugs for diabetes but generally not for obesity alone. Some Advantage plans add coverage—check your formulary.
Can I drink alcohol while on tirzepatide or liraglutide?
Moderate alcohol is not contraindicated, but drinking can worsen nausea and sabotage calorie goals. Limit intake to minimize side effects.
Work with a Weight-Loss Specialist Today
Get a personalized plan, prescription options and price transparency—all without leaving home.